Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:30 AM UTC
| NCT Number | NCT05336201 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 17, 2026: Clinical trial NCT05336201 is currently recruiting participants. This phase2 study for sickle cell disease is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05336201 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05336201 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.